These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32961796)

  • 1. miR-29a Modulates GSK3β/SIRT1-Linked Mitochondrial Proteostatic Stress to Ameliorate Mouse Non-Alcoholic Steatohepatitis.
    Yang YL; Wang PW; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice.
    Yang YL; Kuo HC; Wang FS; Huang YH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
    Lin HY; Wang FS; Yang YL; Huang YH
    Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 29a alleviates mitochondrial stress in diet-induced NAFLD by inhibiting the MAVS pathway.
    Yang YL; Chuang YT; Huang YH
    Eur J Pharmacol; 2024 Nov; 982():176955. PubMed ID: 39209098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.
    Liu MX; Gao M; Li CZ; Yu CZ; Yan H; Peng C; Li Y; Li CG; Ma ZL; Zhao Y; Pu MF; Miao LL; Qi XM; Ren J
    Acta Pharmacol Sin; 2017 May; 38(5):660-671. PubMed ID: 28112179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
    Yang YL; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis.
    Simão AL; Afonso MB; Rodrigues PM; Gama-Carvalho M; Machado MV; Cortez-Pinto H; Rodrigues CMP; Castro RE
    J Mol Med (Berl); 2019 Aug; 97(8):1113-1126. PubMed ID: 31139863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-
    Yang XD; Chen Z; Ye L; Chen J; Yang YY
    Pharm Biol; 2021 Dec; 59(1):922-932. PubMed ID: 34243681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
    Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
    Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes.
    Yousefi Z; Nourbakhsh M; Abdolvahabi Z; Ghorbanhosseini SS; Hesari Z; Yarahmadi S; Ezzati-Mobasser S; Seiri P; Borji M; Meshkani R; Malek M
    J Cell Physiol; 2020 Feb; 235(2):880-890. PubMed ID: 31256424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.
    Liao J; Xie X; Wang N; Wang Y; Zhao J; Chen F; Qu F; Wen W; Miao J; Cui H
    Phytomedicine; 2024 Feb; 124():155285. PubMed ID: 38185065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
    Ao R; Wang Y; Tong J; Wang BF
    Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
    Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
    Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy.
    Stacchiotti A; Grossi I; García-Gómez R; Patel GA; Salvi A; Lavazza A; De Petro G; Monsalve M; Rezzani R
    Cells; 2019 Sep; 8(9):. PubMed ID: 31500354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
    Ding S; Liu D; Wang L; Wang G; Zhu Y
    J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
    Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
    Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.
    Csak T; Bala S; Lippai D; Satishchandran A; Catalano D; Kodys K; Szabo G
    Liver Int; 2015 Feb; 35(2):532-41. PubMed ID: 25040043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.